MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

Momenta Pharmaceuticals Company Profile (NASDAQ:MNTA)

Consensus Ratings for Momenta Pharmaceuticals (NASDAQ:MNTA) (?)
Ratings Breakdown: 1 Sell Rating(s), 3 Buy Rating(s)
Consensus Rating:Buy (Score: 2.50)
Consensus Price Target: $23.00 (0.83% upside)

Analysts' Ratings History for Momenta Pharmaceuticals (NASDAQ:MNTA)
Show:
DateFirmActionRatingPrice TargetActions
6/26/2015Brean CapitalReiterated RatingBuy$31.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/19/2015Stifel NicolausBoost Price TargetBuy$26.00 -> $29.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/19/2015Brean CapitalBoost Price TargetBuy$25.00 -> $31.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/4/2015Stifel NicolausInitiated CoverageBuy$26.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/18/2015Brean CapitalReiterated RatingBuy$25.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/4/2015Leerink SwannBoost Price TargetOutperform$24.00 -> $25.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/17/2015Leerink SwannBoost Price TargetOutperform$16.00 -> $24.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/17/2015Brean CapitalBoost Price TargetBuy$15.00 -> $25.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/19/2015Brean CapitalReiterated RatingBuy$15.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/17/2015Maxim GroupSet Price TargetSell$7.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/23/2015Maxim GroupDowngradeBuy -> Sell$17.00 -> $7.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/7/2015Brean CapitalInitiated CoverageBuy$15.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/5/2014Maxim GroupInitiated CoverageBuy$24.00 -> $17.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/2/2014Goldman SachsInitiated CoverageBuy$19.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/9/2014Maxim GroupInitiated CoverageBuy$24.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/7/2014Bank of AmericaUpgradeUnderperform -> BuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/7/2014Canaccord GenuityReiterated RatingBuy$22.00 -> $17.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/5/2013Sanford C. BernsteinBoost Price TargetOutperform$20.00 -> $24.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/14/2013R. F. LaffertyInitiated CoverageBuy$19.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/29/2013Canaccord GenuityBoost Price Target$13.00 -> $22.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/26/2013Canaccord GenuityUpgradeHold -> BuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/8/2013Sanford C. BernsteinBoost Price TargetBuy$18.00 -> $20.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 7/1/2013 forward)